- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
Searle
Market Cap: PK₨64.8b
Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.
SEARL
PK₨110.08
7D
3.4%
1Y
22.2%
Highnoon Laboratories
Market Cap: PK₨54.5b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,028.09
7D
0.3%
1Y
15.4%
Hoechst Pakistan
Market Cap: PK₨40.8b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,227.66
7D
-12.1%
1Y
53.7%
Abbott Laboratories (Pakistan)
Market Cap: PK₨103.7b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,058.94
7D
3.5%
1Y
-10.4%
GlaxoSmithKline Pakistan
Market Cap: PK₨122.7b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨385.20
7D
-1.4%
1Y
0.6%